Clinical Trial Detail

NCT ID NCT03277638
Title Laser Interstitial Thermotherapy Combined With Checkpoint Inhibitor for Recurrent Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Case Comprehensive Cancer Center
Indications

glioblastoma multiforme

gliosarcoma

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.